2-Ethylhexanoic Acid

2-Ethylhexanoic Acid

SCHEMBL5874743

CCCCC(CC)C(=O)O.CCNCC

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of 2-Ethylhexanoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.80
MAPK1 P28482 2/20 0.80
CA1 P00915 4/20 0.55
SLC1A2 P43004 3/20 0.52
SLC1A1 P43005 3/20 0.52
SLC1A3 P43003 2/20 0.52
CHRM1 P11229 1/20 0.46
AKR1A1 P14550 1/20 0.46
CHRM3 P20309 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
ADRA1A P35348 1/20 0.46
HRH1 P35367 1/20 0.46
DRD3 P35462 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL28327490 0.90 CA2 (0.63) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL5512393 0.89 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL282014 0.89 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL301319 0.89 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL5695779 0.89 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL8387406 0.89 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL25800 0.89 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL8375903 0.89 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL6121661 0.89 CA2 (1.00) CA2MAPK1CA1SLC1A2SLC1A1
2-Ethylhexanoic Acid SCHEMBL25318625 0.87 CA2 (0.95) CA2MAPK1CA1SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11851392-B2 Self-condensation of aldehydes EASTMAN CHEMICAL COMPANY (US) 2023-12-26 US claimed
EP-3880640-A1 SELF-CONDENSATION OF ALDEHYDES Eastman Chemical Company (US) 2021-09-22 EP claimed
CN-112955423-A Self-condensation of aldehydes 伊士曼化工公司 2021-06-11 CN claimed
WO-2020101902-A1 SELF-CONDENSATION OF ALDEHYDES EASTMAN CHEMICAL COMPANY (US) 2020-05-22 WO claimed
JP-9052934-A None JP disclosed
US-11851392-B2 Self-condensation of aldehydes EASTMAN CHEMICAL COMPANY (US) 2023-12-26 US disclosed
US-20210380508-A1 SELF-CONDENSATION OF ALDEHYDES EASTMAN CHEMICAL COMPANY (US) 2021-12-09 US disclosed
EP-3880640-A1 SELF-CONDENSATION OF ALDEHYDES Eastman Chemical Company (US) 2021-09-22 EP disclosed
CN-112955423-A Self-condensation of aldehydes 伊士曼化工公司 2021-06-11 CN disclosed
WO-2020101902-A1 SELF-CONDENSATION OF ALDEHYDES EASTMAN CHEMICAL COMPANY (US) 2020-05-22 WO disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
JP-H0952934-A MATERIAL FOR FORMING RIGID URETHANE FOAM TOYODA GOSEI CO LTD 1997-02-25 JP disclosed
JP-H00952934-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11851392-B2 Self-condensation of aldehydes ALKBH2, DBF4, ALKBH3 CA2 352/4885MAPK1 4256/4885CA1 1070/4885
US-20210380508-A1 SELF-CONDENSATION OF ALDEHYDES ALKBH2, DBF4, ALKBH3 CA2 352/4885MAPK1 4256/4885CA1 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.